Virtu Financial LLC In8 Bio, Inc. Transaction History

Virtu Financial LLC

$1.82 Billion
Q3 2024

A detailed history of Virtu Financial LLC transactions in In8 Bio, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 52,807 shares of INAB stock, worth $17,426. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,807

Holding current value

$17,426

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 20, 2024	BUY	$0.27 - $0.88 $14,257 - $46,470	52,807 New	52,807 $14,000
Q1 2024 May 20, 2024	BUY	$0.95 - $1.69 $13,341 - $23,734	14,044 New	14,044 $17,000

Others Institutions Holding INAB

# of Institutions

Shares Held

7.62M

Call Options Held

Put Options Held

Aigh Capital Management LLC Baltimore, MD

1.67M
Shares

$552,630
0.18% of portfolio
Vanguard Group Inc Valley Forge, PA

1.42M
Shares

$469,886
0.0% of portfolio
683 Capital Management, LLC New York, NY

1.35M
Shares

$445,600
0.03% of portfolio
Sigma Planning Corp Ann Arbor, MI

851K
Shares

$280,922
0.01% of portfolio
Ensign Peak Advisors, Inc Salt Lake City, UT

829K
Shares

$273,628
0.0% of portfolio

View Full List

About IN8BIO, INC.

Ticker INAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,502,200
Market Cap $8.09M
Description
IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...

More about INAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account